| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 20 | 2025 | 300 | 3.730 |
Why?
|
| Brain Injuries | 30 | 2024 | 715 | 1.850 |
Why?
|
| Glasgow Coma Scale | 19 | 2023 | 199 | 1.730 |
Why?
|
| Craniocerebral Trauma | 16 | 2023 | 138 | 1.580 |
Why?
|
| Cerebrovascular Circulation | 21 | 2017 | 476 | 1.560 |
Why?
|
| Intracranial Hypertension | 8 | 2016 | 133 | 1.200 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2017 | 94 | 1.090 |
Why?
|
| Decompressive Craniectomy | 2 | 2017 | 15 | 1.090 |
Why?
|
| Wounds, Gunshot | 6 | 2023 | 145 | 1.080 |
Why?
|
| Disability Evaluation | 3 | 2021 | 194 | 0.890 |
Why?
|
| Hematoma, Subdural, Acute | 2 | 2023 | 12 | 0.850 |
Why?
|
| Head Injuries, Closed | 4 | 2013 | 45 | 0.830 |
Why?
|
| Craniotomy | 5 | 2016 | 108 | 0.810 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2014 | 75 | 0.770 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2023 | 2171 | 0.750 |
Why?
|
| Adult | 69 | 2025 | 31557 | 0.730 |
Why?
|
| Oxygen | 17 | 2015 | 571 | 0.630 |
Why?
|
| Skull Neoplasms | 2 | 2016 | 15 | 0.600 |
Why?
|
| Blood Transfusion | 4 | 2019 | 293 | 0.600 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 117 | 0.580 |
Why?
|
| Xenon | 2 | 2017 | 12 | 0.580 |
Why?
|
| Occipital Bone | 2 | 2016 | 21 | 0.580 |
Why?
|
| Withholding Treatment | 2 | 2021 | 71 | 0.580 |
Why?
|
| Hemoglobins | 3 | 2019 | 321 | 0.570 |
Why?
|
| Zygapophyseal Joint | 1 | 2018 | 4 | 0.570 |
Why?
|
| Intracranial Pressure | 17 | 2015 | 212 | 0.560 |
Why?
|
| Brain Neoplasms | 4 | 2022 | 1411 | 0.550 |
Why?
|
| Restraint, Physical | 1 | 2018 | 26 | 0.550 |
Why?
|
| Intracranial Hemorrhages | 3 | 2021 | 81 | 0.550 |
Why?
|
| Spinal Fractures | 1 | 2018 | 46 | 0.540 |
Why?
|
| Middle Aged | 43 | 2025 | 28936 | 0.540 |
Why?
|
| Life Support Care | 1 | 2017 | 47 | 0.540 |
Why?
|
| Hypernatremia | 1 | 2017 | 32 | 0.530 |
Why?
|
| Injury Severity Score | 5 | 2019 | 229 | 0.530 |
Why?
|
| Monitoring, Physiologic | 10 | 2012 | 380 | 0.530 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2016 | 6 | 0.520 |
Why?
|
| Male | 71 | 2025 | 64918 | 0.520 |
Why?
|
| Morbidity | 1 | 2017 | 253 | 0.520 |
Why?
|
| Skull Base Neoplasms | 2 | 2021 | 36 | 0.500 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2016 | 11 | 0.490 |
Why?
|
| Female | 65 | 2025 | 70680 | 0.490 |
Why?
|
| Meningioma | 4 | 2022 | 141 | 0.490 |
Why?
|
| Hemangioma, Cavernous | 1 | 2016 | 20 | 0.490 |
Why?
|
| Hydrocephalus | 3 | 2017 | 276 | 0.480 |
Why?
|
| Humans | 94 | 2025 | 132105 | 0.480 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2015 | 20 | 0.480 |
Why?
|
| Spinal Puncture | 1 | 2015 | 52 | 0.480 |
Why?
|
| Aneurysm, False | 1 | 2016 | 94 | 0.470 |
Why?
|
| Glasgow Outcome Scale | 7 | 2021 | 48 | 0.470 |
Why?
|
| Recovery of Function | 6 | 2021 | 462 | 0.470 |
Why?
|
| Prospective Studies | 23 | 2025 | 6530 | 0.450 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2014 | 23 | 0.440 |
Why?
|
| Young Adult | 21 | 2023 | 9940 | 0.420 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 18 | 0.410 |
Why?
|
| Frontal Sinus | 1 | 2013 | 13 | 0.410 |
Why?
|
| Meningeal Neoplasms | 3 | 2022 | 216 | 0.400 |
Why?
|
| Encephalocele | 1 | 2013 | 48 | 0.400 |
Why?
|
| Jugular Veins | 12 | 2001 | 76 | 0.390 |
Why?
|
| Lateral Ventricles | 1 | 2012 | 16 | 0.380 |
Why?
|
| Pineal Gland | 1 | 2012 | 22 | 0.380 |
Why?
|
| Germinoma | 1 | 2012 | 32 | 0.370 |
Why?
|
| Brain Abscess | 1 | 2012 | 54 | 0.360 |
Why?
|
| Hematoma | 5 | 1996 | 92 | 0.360 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 1305 | 0.360 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 2011 | 4 | 0.360 |
Why?
|
| Superior Sagittal Sinus | 1 | 2011 | 4 | 0.360 |
Why?
|
| Oxygen Consumption | 9 | 2010 | 304 | 0.350 |
Why?
|
| Brain | 16 | 2022 | 3201 | 0.350 |
Why?
|
| Skull Fractures | 1 | 2011 | 42 | 0.350 |
Why?
|
| Cerebral Hemorrhage | 4 | 1996 | 158 | 0.340 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 32 | 0.340 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 320 | 0.340 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2010 | 20 | 0.340 |
Why?
|
| Extracellular Space | 5 | 2010 | 85 | 0.330 |
Why?
|
| Infratentorial Neoplasms | 1 | 2010 | 48 | 0.330 |
Why?
|
| Pituitary Neoplasms | 1 | 2011 | 83 | 0.320 |
Why?
|
| Aged | 20 | 2021 | 21413 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 3854 | 0.300 |
Why?
|
| Cognitive Dysfunction | 2 | 2025 | 313 | 0.300 |
Why?
|
| Postoperative Complications | 3 | 2017 | 3146 | 0.300 |
Why?
|
| Erythropoietin | 4 | 2019 | 109 | 0.290 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 189 | 0.290 |
Why?
|
| Brain Ischemia | 4 | 1999 | 277 | 0.280 |
Why?
|
| Adolescent | 23 | 2019 | 20532 | 0.280 |
Why?
|
| Prognosis | 12 | 2021 | 5008 | 0.280 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 203 | 0.280 |
Why?
|
| Treatment Outcome | 13 | 2021 | 13017 | 0.280 |
Why?
|
| Spectrophotometry, Infrared | 3 | 1995 | 26 | 0.250 |
Why?
|
| Retrospective Studies | 14 | 2024 | 17374 | 0.250 |
Why?
|
| Oximetry | 5 | 1998 | 178 | 0.240 |
Why?
|
| Survival Rate | 4 | 2017 | 2186 | 0.240 |
Why?
|
| Microdialysis | 10 | 2010 | 57 | 0.240 |
Why?
|
| Brain Edema | 2 | 2010 | 71 | 0.240 |
Why?
|
| Monitoring, Intraoperative | 3 | 1997 | 132 | 0.240 |
Why?
|
| Glutamic Acid | 2 | 2010 | 209 | 0.220 |
Why?
|
| Transducers, Pressure | 2 | 1995 | 11 | 0.220 |
Why?
|
| Age Factors | 4 | 2017 | 2922 | 0.220 |
Why?
|
| Brain Concussion | 3 | 2021 | 238 | 0.210 |
Why?
|
| Erythrocyte Transfusion | 2 | 2015 | 139 | 0.200 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 5399 | 0.200 |
Why?
|
| Firearms | 1 | 2023 | 57 | 0.200 |
Why?
|
| Critical Care | 5 | 2016 | 686 | 0.190 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2021 | 12 | 0.180 |
Why?
|
| Skull | 1 | 2023 | 144 | 0.180 |
Why?
|
| Neurosurgery | 1 | 2022 | 82 | 0.180 |
Why?
|
| Anesthesia | 1 | 2024 | 209 | 0.180 |
Why?
|
| Surgical Flaps | 1 | 2023 | 192 | 0.180 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2021 | 7 | 0.180 |
Why?
|
| Post-Concussion Syndrome | 1 | 2021 | 50 | 0.170 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 1541 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 3083 | 0.170 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 1495 | 0.170 |
Why?
|
| Radiography | 2 | 2014 | 818 | 0.170 |
Why?
|
| Risk Factors | 7 | 2025 | 10902 | 0.170 |
Why?
|
| Head Injuries, Penetrating | 1 | 2019 | 6 | 0.160 |
Why?
|
| Lactic Acid | 6 | 2022 | 154 | 0.160 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
| Aspartic Acid | 1 | 2000 | 84 | 0.160 |
Why?
|
| Cognition | 2 | 2023 | 810 | 0.150 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 1451 | 0.150 |
Why?
|
| Astrocytes | 1 | 2022 | 270 | 0.150 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2010 | 93 | 0.150 |
Why?
|
| Cytokines | 2 | 2019 | 1367 | 0.140 |
Why?
|
| Braces | 1 | 2018 | 14 | 0.140 |
Why?
|
| Erdheim-Chester Disease | 1 | 2017 | 28 | 0.140 |
Why?
|
| Radiographic Image Enhancement | 1 | 2017 | 45 | 0.140 |
Why?
|
| Hemodynamics | 4 | 2015 | 864 | 0.130 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 7119 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 145 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 2306 | 0.130 |
Why?
|
| Patient Care | 1 | 2017 | 98 | 0.130 |
Why?
|
| Aftercare | 1 | 2018 | 155 | 0.130 |
Why?
|
| Occipital Lobe | 1 | 2016 | 34 | 0.130 |
Why?
|
| Seizures | 2 | 2013 | 895 | 0.130 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2017 | 37 | 0.130 |
Why?
|
| Cohort Studies | 6 | 2023 | 5150 | 0.120 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 21 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 742 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 222 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 165 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2017 | 312 | 0.120 |
Why?
|
| Ventriculostomy | 1 | 1995 | 44 | 0.120 |
Why?
|
| Hypoxia, Brain | 3 | 2001 | 36 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2017 | 1569 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2019 | 815 | 0.110 |
Why?
|
| Adie Syndrome | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cauda Equina | 1 | 2014 | 8 | 0.110 |
Why?
|
| Laminectomy | 1 | 2014 | 24 | 0.110 |
Why?
|
| Time Factors | 6 | 2021 | 6445 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1443 | 0.110 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 225 | 0.110 |
Why?
|
| Laughter | 1 | 1994 | 10 | 0.110 |
Why?
|
| Disease Management | 1 | 2018 | 564 | 0.110 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 11 | 0.100 |
Why?
|
| Disease Progression | 2 | 2019 | 2227 | 0.100 |
Why?
|
| Depressive Disorder, Major | 1 | 2019 | 461 | 0.100 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2013 | 43 | 0.100 |
Why?
|
| Trauma Centers | 4 | 2021 | 198 | 0.100 |
Why?
|
| Injections, Spinal | 1 | 2013 | 136 | 0.100 |
Why?
|
| Blood Gas Analysis | 4 | 2008 | 86 | 0.100 |
Why?
|
| Lipoma | 1 | 1992 | 26 | 0.100 |
Why?
|
| Logistic Models | 2 | 2014 | 1837 | 0.100 |
Why?
|
| Meningitis, Bacterial | 1 | 2013 | 97 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 246 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1252 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 651 | 0.090 |
Why?
|
| Motorcycles | 1 | 2011 | 6 | 0.090 |
Why?
|
| Hypophysectomy | 1 | 2011 | 20 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 2553 | 0.090 |
Why?
|
| Neurophysins | 1 | 2010 | 4 | 0.090 |
Why?
|
| Quality of Life | 1 | 2021 | 2152 | 0.090 |
Why?
|
| Hyperventilation | 1 | 2010 | 14 | 0.090 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 11 | 0.080 |
Why?
|
| Incidence | 5 | 2021 | 3365 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2021 | 3714 | 0.080 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 109 | 0.080 |
Why?
|
| Vasopressins | 1 | 2010 | 45 | 0.080 |
Why?
|
| Biomarkers | 2 | 2019 | 3380 | 0.080 |
Why?
|
| Whipple Disease | 1 | 2010 | 6 | 0.080 |
Why?
|
| Consciousness | 1 | 2010 | 46 | 0.080 |
Why?
|
| Cerebrum | 1 | 2010 | 38 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 190 | 0.080 |
Why?
|
| Anemia | 1 | 2014 | 349 | 0.080 |
Why?
|
| Headache | 1 | 2011 | 110 | 0.080 |
Why?
|
| Central Nervous System Infections | 1 | 2010 | 22 | 0.080 |
Why?
|
| Palliative Care | 1 | 2014 | 457 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 83 | 0.080 |
Why?
|
| Protein Precursors | 1 | 2010 | 156 | 0.080 |
Why?
|
| Embolism | 1 | 2009 | 47 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2012 | 323 | 0.080 |
Why?
|
| Pupil | 1 | 2009 | 56 | 0.080 |
Why?
|
| Neurocysticercosis | 1 | 2009 | 27 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 3 | 1999 | 137 | 0.070 |
Why?
|
| Persistent Vegetative State | 2 | 2021 | 10 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 236 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2009 | 124 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2016 | 784 | 0.070 |
Why?
|
| Pentobarbital | 2 | 1999 | 20 | 0.070 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2009 | 260 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 341 | 0.070 |
Why?
|
| Inflammation | 2 | 2023 | 1522 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 1966 | 0.070 |
Why?
|
| Arthrography | 1 | 2007 | 6 | 0.070 |
Why?
|
| Spondylolisthesis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Neurologic Examination | 3 | 2014 | 202 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 53 | 0.060 |
Why?
|
| Joint Instability | 1 | 2007 | 59 | 0.060 |
Why?
|
| United States | 4 | 2023 | 11627 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 1999 | 484 | 0.060 |
Why?
|
| Hyperoxia | 1 | 2008 | 130 | 0.060 |
Why?
|
| Body Temperature | 2 | 1998 | 128 | 0.060 |
Why?
|
| Smoking | 1 | 2011 | 942 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2009 | 373 | 0.060 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 1995 | 8 | 0.060 |
Why?
|
| Hematoma, Subdural | 2 | 1995 | 25 | 0.060 |
Why?
|
| Obesity | 1 | 2016 | 2396 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2025 | 188 | 0.050 |
Why?
|
| Coma | 3 | 1999 | 57 | 0.050 |
Why?
|
| Emergency Service, Hospital | 3 | 2019 | 1161 | 0.050 |
Why?
|
| Neuroprotection | 1 | 2022 | 31 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 84 | 0.050 |
Why?
|
| Child | 4 | 2014 | 25758 | 0.040 |
Why?
|
| Workload | 1 | 2022 | 150 | 0.040 |
Why?
|
| Xanthine | 1 | 2001 | 6 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 2 | 1999 | 64 | 0.040 |
Why?
|
| Carbon Dioxide | 3 | 1997 | 275 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2001 | 118 | 0.040 |
Why?
|
| Excitatory Amino Acids | 2 | 1998 | 9 | 0.040 |
Why?
|
| Cholesterol | 1 | 2023 | 559 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1408 | 0.040 |
Why?
|
| Brain Death | 2 | 1998 | 73 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2021 | 324 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 3358 | 0.040 |
Why?
|
| Adenosine | 1 | 2001 | 135 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 438 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 553 | 0.040 |
Why?
|
| Anaerobic Threshold | 1 | 1998 | 11 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 428 | 0.040 |
Why?
|
| Magnesium | 1 | 1999 | 114 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 553 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 899 | 0.040 |
Why?
|
| Pamphlets | 1 | 2018 | 24 | 0.040 |
Why?
|
| Hypotension | 2 | 1998 | 183 | 0.040 |
Why?
|
| Probability | 1 | 2019 | 323 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1996 | 70 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 1999 | 524 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 1246 | 0.040 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2017 | 6 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1997 | 373 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 37 | 0.030 |
Why?
|
| Glucose | 2 | 1999 | 878 | 0.030 |
Why?
|
| Rewarming | 1 | 1997 | 12 | 0.030 |
Why?
|
| Potassium | 1 | 1999 | 272 | 0.030 |
Why?
|
| Catheterization, Peripheral | 1 | 1999 | 131 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1999 | 1008 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2021 | 989 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 564 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 611 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 258 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2025 | 922 | 0.030 |
Why?
|
| Partial Pressure | 2 | 2012 | 28 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 1997 | 85 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 482 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 86 | 0.030 |
Why?
|
| Hypertension | 1 | 2025 | 1388 | 0.030 |
Why?
|
| Rabbits | 2 | 1997 | 688 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2001 | 1121 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2017 | 130 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2017 | 437 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2016 | 212 | 0.030 |
Why?
|
| Miniaturization | 1 | 1995 | 26 | 0.030 |
Why?
|
| Pseudotumor Cerebri | 1 | 1996 | 66 | 0.030 |
Why?
|
| Arteries | 1 | 1996 | 221 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 188 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 1891 | 0.030 |
Why?
|
| Catheterization | 1 | 1996 | 241 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1995 | 77 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 3021 | 0.030 |
Why?
|
| Calibration | 1 | 1994 | 99 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2142 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 436 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2730 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 260 | 0.030 |
Why?
|
| Equipment Failure | 1 | 1994 | 136 | 0.030 |
Why?
|
| Chordoma | 1 | 1994 | 19 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1995 | 157 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1035 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1606 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 1995 | 170 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 1083 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2014 | 93 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 1993 | 58 | 0.030 |
Why?
|
| Brain Stem | 1 | 1994 | 118 | 0.030 |
Why?
|
| Amino Acids | 1 | 1996 | 626 | 0.020 |
Why?
|
| Reference Values | 1 | 2014 | 704 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 1589 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1992 | 107 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1879 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2012 | 38 | 0.020 |
Why?
|
| Prevalence | 1 | 2019 | 2659 | 0.020 |
Why?
|
| Neurons | 1 | 2022 | 2016 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3418 | 0.020 |
Why?
|
| Recurrence | 1 | 1995 | 1454 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3982 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 319 | 0.020 |
Why?
|
| Equipment Design | 1 | 1993 | 611 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 1995 | 415 | 0.020 |
Why?
|
| Vacuum | 1 | 2010 | 11 | 0.020 |
Why?
|
| Syringes | 1 | 2010 | 24 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2010 | 56 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 598 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2001 | 1396 | 0.020 |
Why?
|
| Optical Fibers | 1 | 2009 | 19 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 119 | 0.020 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2009 | 19 | 0.020 |
Why?
|
| Glycolysis | 2 | 2001 | 165 | 0.020 |
Why?
|
| Antiparasitic Agents | 1 | 2009 | 31 | 0.020 |
Why?
|
| Infant | 2 | 1995 | 13039 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2001 | 351 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 710 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 174 | 0.020 |
Why?
|
| Child, Preschool | 2 | 1995 | 14718 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1085 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 586 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 305 | 0.020 |
Why?
|
| Homeostasis | 1 | 2010 | 723 | 0.020 |
Why?
|
| Catheterization, Central Venous | 2 | 1999 | 139 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 189 | 0.020 |
Why?
|
| Observer Variation | 1 | 2007 | 307 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 2007 | 114 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 989 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 1161 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2706 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2011 | 1581 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7551 | 0.010 |
Why?
|
| Nervous System | 1 | 2001 | 127 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 234 | 0.010 |
Why?
|
| Diuretics, Osmotic | 1 | 1999 | 4 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 796 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2000 | 214 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 1999 | 89 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1999 | 56 | 0.010 |
Why?
|
| Animals | 3 | 1997 | 34953 | 0.010 |
Why?
|
| Cations | 1 | 1998 | 39 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 439 | 0.010 |
Why?
|
| Anesthesia, Endotracheal | 1 | 1997 | 4 | 0.010 |
Why?
|
| Oxygenators, Membrane | 1 | 1997 | 8 | 0.010 |
Why?
|
| Drainage | 1 | 1999 | 265 | 0.010 |
Why?
|
| Hypoxia | 1 | 1999 | 259 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1997 | 16 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 1997 | 153 | 0.010 |
Why?
|
| Critical Illness | 1 | 2001 | 617 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 1176 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1995 | 65 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1995 | 60 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 868 | 0.010 |
Why?
|
| Vena Cava, Superior | 1 | 1995 | 60 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 1999 | 471 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1995 | 109 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 448 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1995 | 443 | 0.010 |
Why?
|
| Swine | 1 | 1995 | 1197 | 0.010 |
Why?
|